Allergan plc
https://www.allerganaesthetics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Allergan plc
Biosimilar Antibody-Drug Conjugates? Pfizer Isn’t Banking On It
Pfizer’s $43bn agreement to acquire Seagen would layer its portfolio and pipeline with vastly complex antibody-drug conjugates – a class of drug that execs feel might be almost immune to biosimilar competition. Generic firms’ history of frustration with ADCs suggests they may be right.
Galderma Readies Its First Therapeutic Biologic For Two US Launches In 2024
Galderma said its IL-31 receptor alpha inhibitor nemolizumab succeeded in two Phase III atopic dermatitis trials, advancing the firm’s long-term goal of moving past topical dermatology drugs.
Pfizer-gen? Pfizer Is The Latest Rumored Suitor For Seagen
Pfizer and Seagen reportedly are in merger discussions, signaling Pfizer’s willingness to invest significantly in antibody-drug conjugates (ADCs) for cancer.
Bausch + Lomb Turns To Familiar Face As CEO, Brent Saunders
Saunders will oversee the consumer health, pharma and medtech eye health and vision care specialist, returning to where he got his start as a chief executive before earning a reputation as one of industry’s biggest dealmakers.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- OTC, Consumer
- Specialty Pharmaceuticals
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- Actavis, Inc.
- Actavis plc
- Akarna Therapeutics Ltd.
- Allergan Aesthetics
- Allergan, Inc.
- Anterios, Inc.
- Arrow Group (Subsidiaries: Arrow Generics (U.K), Cobalt Group (U.S.))
- AqueSys, Inc.
- Bonti, Inc.
- Chase Pharmaceuticals Corporation, Inc.
- Durata Therapeutics
- Elastagen Pty Ltd
- EndoArt SA
- Envy Medical, Inc.
- Forest Laboratories [Aptalis Pharmaceutical Technologies
- (Axcan Pharma, Inc.
- Eurand N.V.
- Mpex Pharmaceuticals, Inc.)
- Cerexa, Inc.
- Clinical Data, Inc.]
- Furiex Pharmaceuticals, Inc. (PPD, Inc.)
- Kythera Biopharmaceuticals, Inc.
- MAP Pharmaceuticals
- Motus Therapeutics, Inc. (Rhythm Health, Inc.)
- Naurex, Inc.
- Oculeve
- Regado Biosciences, Inc.
- RetroSense Therapeutics, LLC
- Silom Medical Company
- Uteron Pharma SA
- Warner Chilcott PLC (Galen Holdings PLC)
- Watson Pharmaceuticals, Inc.
- Tobira Therapeutics, Inc.
- Topokine Therapeutics
- Vitae Pharmaceuticals, Inc.
- ForSight VISION5, Inc.
- LifeCell Corporation
- ZELTIQ Aesthetics, Inc.
- Zonagen, Inc.
- Repros Therapeutics, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice